chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site mass, Vaccination site rash
Clinical narrative: Big knot (injection site); Rash (injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MASS (Big knot (injection site)) and VACCINATION SITE RASH (Rash (injection site)) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced VACCINATION SITE MASS (Big knot (injection site)) and VACCINATION SITE RASH (Rash (injection site)). At the time of the report, VACCINATION SITE MASS (Big knot (injection site)) and VACCINATION SITE RASH (Rash (injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. No treatment information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Taste disorder, Vaccination site pain
Clinical narrative: she experienced a bad taste in her mouth "like she has medicine" and is fatigued. She has soreness experienced a bad taste in her mouth "like she has medicine".; fatigue; soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (she experienced a bad taste in her mouth "like she has medicine" and is fatigued. She has soreness experienced a bad taste in her mouth "like she has medicine".), FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness in her arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032120A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced TASTE DISORDER (she experienced a bad taste in her mouth "like she has medicine" and is fatigued. She has soreness experienced a bad taste in her mouth "like she has medicine".), FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness in her arm). At the time of the report, TASTE DISORDER (she experienced a bad taste in her mouth "like she has medicine" and is fatigued. She has soreness experienced a bad taste in her mouth "like she has medicine".), FATIGUE (fatigue) and VACCINATION SITE PAIN (soreness in her arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Vaccination site erythema, Vaccination site mass
Clinical narrative: small lump, like a ball at the injection site; It is red; muscle soreness in the arm of the injection; This spontaneous case was reported by a pharmacist and describes the occurrence of MYALGIA (muscle soreness in the arm of the injection), VACCINATION SITE MASS (small lump, like a ball at the injection site) and VACCINATION SITE ERYTHEMA (It is red) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced MYALGIA (muscle soreness in the arm of the injection). On 02-Feb-2021, the patient experienced VACCINATION SITE MASS (small lump, like a ball at the injection site) and VACCINATION SITE ERYTHEMA (It is red). At the time of the report, MYALGIA (muscle soreness in the arm of the injection) had resolved and VACCINATION SITE MASS (small lump, like a ball at the injection site) and VACCINATION SITE ERYTHEMA (It is red) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided. No relevant concomitant medications were reported.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Peripheral swelling
Clinical narrative: swelling of her arm; Hurting of her arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling of her arm) and PAIN IN EXTREMITY (Hurting of her arm) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PERIPHERAL SWELLING (swelling of her arm) and PAIN IN EXTREMITY (Hurting of her arm). At the time of the report, PERIPHERAL SWELLING (swelling of her arm) and PAIN IN EXTREMITY (Hurting of her arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided. On 03Feb2021, her symptoms are back to what they were and are just as bad as originally.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: Rash near injection site. Rash size of apple. 2-3inch in Diameter; Soreness from initial injection on day 1; A spontaneous case report from united states from  an Other Health Professional on 26-JAN-2021 , which refers to a Female aged 25 Years.  On 16JAN2021  the patient received Moderna COVID-19 Vaccine for COVID-19 vaccination.   the patient developed Rash near injection site. Rash size of apple. 2-3inch in Diamete, .after receiving first dose of Moderna Vaccine. 1st dose was on 16JAN2021(Batch Number 042L20A) intramuscular route. Symptoms started 2 day later on Monday 18JAN2021. Rash right near injection site. Rash size of an apple. 2-3inch in diameter. Had soreness from initial injection on day 1. The soreness went away on the same day. :. The eventual diagnosis made on was Vaccination site rash . Not taking any medications to treat symptoms.  Currently on no medications. Second dose on 13FEb2021. Laboratory details were not provided.  Action taken with mRNA-1273 in response to the events was not reported.      The outcome of reported events fever was recovering and outcome of Rash near injection site  was unknown and soreness of injection site was recovered.  The reporter assessment for the event(s) were not provided.     Terse Narrative (for PSUR narratives and signal review) Brief 3 line summary of above for CIOMS listing: Report Source- Other Health Professional,  Age- 25 Years,  Sex- Female,  Suspect Drug- Moderna COVID-19 Vaccine,  Treatment-    Diagnosis\Outcome- Rash near injection site. Rash size of apple. 2-3inch in Diameter - Unknown,Soreness from initial injection on day 1 - Recovered/Resolved.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Pain
Clinical narrative: feel like I was hit by a bus; Back pain; hip pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (feel like I was hit by a bus), BACK PAIN (Back pain) and PAIN (hip pain) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for an unknown indication.     Concurrent medical conditions included Arthritis (hip arthritis). Concomitant products included IBUPROFEN for Arthritis.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced PAIN (feel like I was hit by a bus), BACK PAIN (Back pain) and PAIN (hip pain). At the time of the report, PAIN (feel like I was hit by a bus) and BACK PAIN (Back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information is not provided.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pain, Rash
Clinical narrative: Painful rash; Red rash; Itchy rash; Achy; Myalgia; Fatigue; headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash), PAIN (Achy) and MYALGIA (Myalgia) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported adverse event). Concomitant products included HydroDiuril  Blood pressure medication for Hypertension, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced MYALGIA (Myalgia), FATIGUE (Fatigue) and HEADACHE (headache). On 20-Jan-2021, the patient experienced RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash) and PAIN (Achy). At the time of the report, RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash), PAIN (Achy), MYALGIA (Myalgia), FATIGUE (Fatigue) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Rash erythematous, Rash pruritic
Clinical narrative: Painful rash; Red rash; Itchy rash; Achy; Myalgia; Fatigue; headache; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash), PAIN (Achy) and MYALGIA (Myalgia) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported adverse event). Concomitant products included HydroDiuril  Blood pressure medication for Hypertension, OMEPRAZOLE (PROTONIX [OMEPRAZOLE]) for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced MYALGIA (Myalgia), FATIGUE (Fatigue) and HEADACHE (headache). On 20-Jan-2021, the patient experienced RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash) and PAIN (Achy). At the time of the report, RASH (Painful rash), RASH ERYTHEMATOUS (Red rash), RASH PRURITIC (Itchy rash), PAIN (Achy), MYALGIA (Myalgia), FATIGUE (Fatigue) and HEADACHE (headache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Fatigue, Heart rate irregular, Hyperhidrosis
Clinical narrative: feeling lightheaded; heart rate has been flactuating; diarrhea; clummy; fatigued; nausea; This spontaneous case was reported by an other and describes the occurrence of DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy) and FATIGUE (fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 22-Jan-2021, the patient experienced DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy), FATIGUE (fatigued) and NAUSEA (nausea). At the time of the report, DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy), FATIGUE (fatigued) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: feeling lightheaded; heart rate has been flactuating; diarrhea; clummy; fatigued; nausea; This spontaneous case was reported by an other and describes the occurrence of DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy) and FATIGUE (fatigued) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form. On 22-Jan-2021, the patient experienced DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy), FATIGUE (fatigued) and NAUSEA (nausea). At the time of the report, DIZZINESS (feeling lightheaded), HEART RATE IRREGULAR (heart rate has been flactuating), DIARRHOEA (diarrhea), HYPERHIDROSIS (clummy), FATIGUE (fatigued) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.    Reporter did not allow further contact
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Chills, Fatigue, Headache
Clinical narrative: wasn't able to really exercise, started to feel feverish, ill, wasn't able to work; body ache; nauseous; fever 102.2 ºF; joint pain; chills; fatigue; pain under armpit; became increadibly ill; lymph node pain; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of MALAISE (became increadibly ill), HEART RATE (low hear rate), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 infection in March 2020.) in March 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MALAISE (became increadibly ill), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache), PAIN (body ache), NAUSEA (nauseous), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit). On an unknown date, the patient experienced HEART RATE (low hear rate) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work). On 22-Jan-2021, MALAISE (became increadibly ill), PAIN (body ache), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain) and CHILLS (chills) had resolved. At the time of the report, LYMPH NODE PAIN (lymph node pain), MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work), NAUSEA (nauseous), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is 5 months Post Partum and not Breast feeding.  Treatment Medicines include Motrin and Tylenol
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Heart rate, Lymph node pain, Malaise, Myalgia, Nausea
Clinical narrative: wasn't able to really exercise, started to feel feverish, ill, wasn't able to work; body ache; nauseous; fever 102.2 ºF; joint pain; chills; fatigue; pain under armpit; became increadibly ill; lymph node pain; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of MALAISE (became increadibly ill), HEART RATE (low hear rate), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 infection in March 2020.) in March 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MALAISE (became increadibly ill), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache), PAIN (body ache), NAUSEA (nauseous), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit). On an unknown date, the patient experienced HEART RATE (low hear rate) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work). On 22-Jan-2021, MALAISE (became increadibly ill), PAIN (body ache), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain) and CHILLS (chills) had resolved. At the time of the report, LYMPH NODE PAIN (lymph node pain), MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work), NAUSEA (nauseous), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is 5 months Post Partum and not Breast feeding.  Treatment Medicines include Motrin and Tylenol
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: wasn't able to really exercise, started to feel feverish, ill, wasn't able to work; body ache; nauseous; fever 102.2 ºF; joint pain; chills; fatigue; pain under armpit; became increadibly ill; lymph node pain; headache; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of MALAISE (became increadibly ill), HEART RATE (low hear rate), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (Had Covid-19 infection in March 2020.) in March 2020.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced MALAISE (became increadibly ill), LYMPH NODE PAIN (lymph node pain), HEADACHE (headache), PAIN (body ache), NAUSEA (nauseous), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain), CHILLS (chills), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit). On an unknown date, the patient experienced HEART RATE (low hear rate) and MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work). On 22-Jan-2021, MALAISE (became increadibly ill), PAIN (body ache), PYREXIA (fever 102.2 ºF), ARTHRALGIA (joint pain) and CHILLS (chills) had resolved. At the time of the report, LYMPH NODE PAIN (lymph node pain), MALAISE (wasn't able to really exercise, started to feel feverish, ill, wasn't able to work), NAUSEA (nauseous), FATIGUE (fatigue) and AXILLARY PAIN (pain under armpit) outcome was unknown and HEADACHE (headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient is 5 months Post Partum and not Breast feeding.  Treatment Medicines include Motrin and Tylenol
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Influenza like illness, Pain, Pyrexia
Clinical narrative: Flu like symptoms; Body aches; Headaches; Low fever; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (Low fever) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (Low fever). On 09-Jan-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms), PAIN (Body aches), HEADACHE (Headaches) and PYREXIA (Low fever) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Muscle spasms, Pain, Pruritus
Clinical narrative: itching; Muscle spasms; body aches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), MUSCLE SPASMS (Muscle spasms), PAIN (body aches) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PRURITUS (itching), MUSCLE SPASMS (Muscle spasms), PAIN (body aches) and FATIGUE (fatigue). At the time of the report, PRURITUS (itching), MUSCLE SPASMS (Muscle spasms), PAIN (body aches) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-047944 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-047944:Crosslinked (MOD21-018111) US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018111)
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Vaccination site pain
Clinical narrative: little pain at site of injection; headache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little pain at site of injection) and HEADACHE (headache) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (little pain at site of injection) and HEADACHE (headache). At the time of the report, VACCINATION SITE PAIN (little pain at site of injection) and HEADACHE (headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Diarrhoea, Fatigue, Haematocrit decreased, Musculoskeletal pain
Clinical narrative: Diarrhea; HCT level has been low; Patient states that his butt hurt.; tired; Soreness in the arm; A spontaneous report (United States) was received from a Consumer concerning a 66 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness in the arm(Pain in extremity), tired(Fatigue), diarrhea, patient states that his butt hurt(Musculoskeletal pain), hct level has been low(Haematocrit decreased).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Jan 2021, the patient experienced the events soreness in the arm. tired. On an unknown date, the patient experienced the events Diarrhea. Patient states that his butt hurt., HCT level has been low.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, soreness in the arm, tired, diarrhea, patient states that his butt hurt, hct level has been lowwas not reported.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Diarrhea; HCT level has been low; Patient states that his butt hurt.; tired; Soreness in the arm; A spontaneous report (United States) was received from a Consumer concerning a 66 years old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events soreness in the arm(Pain in extremity), tired(Fatigue), diarrhea, patient states that his butt hurt(Musculoskeletal pain), hct level has been low(Haematocrit decreased).  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 2 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 3 Jan 2021, the patient experienced the events soreness in the arm. tired. On an unknown date, the patient experienced the events Diarrhea. Patient states that his butt hurt., HCT level has been low.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   On an unknown date the outcome of events, soreness in the arm, tired, diarrhea, patient states that his butt hurt, hct level has been lowwas not reported.
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: minor soreness at the injection site; minor tenderness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site) in a 93-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Cholesterol and Glaucoma. Concomitant products included IBUPROFEN for Pain.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site). At the time of the report, VACCINATION SITE PAIN (minor soreness at the injection site) and VACCINATION SITE PAIN (minor tenderness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant information provided. No treatment information provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Swelling; Red area; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling) and INJECTION SITE ERYTHEMA (Red area) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (beta blockers and other drugs). Concomitant products included DILTIAZEM, APIXABAN (ELIQUIS), FLECAINIDE, ALENDRONATE SODIUM (FOSAMAX), PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) and TELMISARTAN (MICARDIS) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced INJECTION SITE SWELLING (Swelling) and INJECTION SITE ERYTHEMA (Red area). At the time of the report, INJECTION SITE SWELLING (Swelling) and INJECTION SITE ERYTHEMA (Red area) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site bruising, Pain
Clinical narrative: big bruise at injection site; some pain during the night; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (some pain during the night) and INJECTION SITE BRUISING (big bruise at injection site) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, the patient experienced PAIN (some pain during the night). On 02-Feb-2021, the patient experienced INJECTION SITE BRUISING (big bruise at injection site). At the time of the report, PAIN (some pain during the night) and INJECTION SITE BRUISING (big bruise at injection site) outcome was unknown. Not provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Products known to have been used by the patient were  medicines for high blood pressure, to help her urinate and for "palpitations" of the heart. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Nosocomial infection
Clinical narrative: Hospital; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 03-Feb-2021 and was forwarded to Moderna on 04-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of NOSOCOMIAL INFECTION (Hospital) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NOSOCOMIAL INFECTION (Hospital). At the time of the report, NOSOCOMIAL INFECTION (Hospital) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Dyspnoea, Headache
Clinical narrative: chest pain; shortness of breath; HEADACHE; CHILLS; A spontaneous report  was received from a Consumer concerning a 41-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headache, chills, chest pain, shortness of breath.  The patient's medical history was not provided. Concomitant medications reported were Supplements for unknown indication.  On 22 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 23 Jan 2021, the patient experienced the event(s) headache . On 23 Jan 2021, the patient experienced the event(s) chills . On 23 Jan 2021, the patient experienced the event(s) chest pain . On 23 Jan 2021, the patient experienced the event(s) shortness of breath.  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), headache was unknown.The outcome of event(s), chills was unknown.The outcome of event(s), chest pain was unknown.The outcome of event(s), shortness of breath was unknown..
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site induration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Arm was really sore and hurting when I touched; arm was really red; Feeling itching; Hardness; A spontaneous report was received from a Healthcare Professional concerning a 74-years-old  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events arm was really sore, really red, hurting when touched, still have redness today after 12 days, itching, hardness.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 21 Jan 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch:  043L20A) intramuscularly for prophylaxis of COVID-19 infection.  On an unknown date, the patient experienced arm was really sore, really red, hurting when touched, still have redness today after 12 days, On 21 Jan 2021, the patient experienced itching, hardness.  Treatment details not ncluded   Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events arm was really sore, really red, hurting when touched,still have redness today after 12 days,itching, hardness as unknown..
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: mild chills; soreness near the injection site; temperature of 100.3; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHILLS (mild chills), VACCINATION SITE PAIN (soreness near the injection site) and PYREXIA (temperature of 100.3) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis (arthritis pain). Concomitant products included NAPROXEN SODIUM (ALEVE) for Arthritis, METFORMIN and ATORVASTATIN CALCIUM (ATORVASTIN) for an unknown indication.    On 27-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced CHILLS (mild chills), VACCINATION SITE PAIN (soreness near the injection site) and PYREXIA (temperature of 100.3). At the time of the report, CHILLS (mild chills), VACCINATION SITE PAIN (soreness near the injection site) and PYREXIA (temperature of 100.3) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       CONCOMITANT MEDICATION INCLUDE WATER PILL,METFORMIN,ATORVASTIN
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Headache, Pain in extremity, Peripheral swelling, Vaccination site pruritus
Clinical narrative: swelling of the upper arm up to the shoulder; he injection site began to itch profusely (terrible itching); intense redness on the arm; pain on her arm; soreness on the arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), PAIN IN EXTREMITY (soreness on the arm), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included METFORMIN, ATORVASTATIN CALCIUM (LIPITOR), MULTIVITAMIN & MINERAL, CYANOCOBALAMIN (B12 1000 SR), CALCIUM, MAGNESIUM and ZINC for an unknown indication.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, the patient experienced PAIN IN EXTREMITY (soreness on the arm). On 22-Jan-2021, the patient experienced PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE, PARACETAMOL, PHENYLEPHRINE HYDROCHLORIDE (BENADRYL ALLERGY & COLD) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (swelling of the upper arm up to the shoulder), VACCINATION SITE PRURITUS (he injection site began to itch profusely (terrible itching)), PAIN IN EXTREMITY (soreness on the arm), ERYTHEMA (intense redness on the arm) and HEADACHE (pain on her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Pain, Somnolence, Swelling
Clinical narrative: It is very tender; Swelling and puffing; It is very sore when in motion; Awaken with arthralgia right elbow; Sleepiness; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of SOMNOLENCE (Sleepiness), TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and FATIGUE (Fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID, CAFFEINE, CARBINOXAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (CAPRAMIN [ACETYLSALICYLIC ACID;CAFFEINE;CARBINOXAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]), ATORVASTATIN, METOPROLOL, DOFETILIDE (TIKOSYN), RIVAROXABAN (XARELTO) and OMEPRAZOLE for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (Sleepiness) and FATIGUE (Fatigue). On 22-Feb-2021, the patient experienced TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and ARTHRALGIA (Awaken with arthralgia right elbow). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Feb-2021, SOMNOLENCE (Sleepiness) and FATIGUE (Fatigue) had resolved. At the time of the report, TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and ARTHRALGIA (Awaken with arthralgia right elbow) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MODERNATX, INC.-MOD-2021-020521 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-020521:Same patient, 1st dose
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Tenderness
Clinical narrative: It is very tender; Swelling and puffing; It is very sore when in motion; Awaken with arthralgia right elbow; Sleepiness; Fatigue; This spontaneous case was reported by a health care professional and describes the occurrence of SOMNOLENCE (Sleepiness), TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and FATIGUE (Fatigue) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included ACETYLSALICYLIC ACID, CAFFEINE, CARBINOXAMINE MALEATE, PHENYLEPHRINE HYDROCHLORIDE (CAPRAMIN [ACETYLSALICYLIC ACID;CAFFEINE;CARBINOXAMINE MALEATE;PHENYLEPHRINE HYDROCHLORIDE]), ATORVASTATIN, METOPROLOL, DOFETILIDE (TIKOSYN), RIVAROXABAN (XARELTO) and OMEPRAZOLE for an unknown indication.   On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced SOMNOLENCE (Sleepiness) and FATIGUE (Fatigue). On 22-Feb-2021, the patient experienced TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and ARTHRALGIA (Awaken with arthralgia right elbow). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. On 19-Feb-2021, SOMNOLENCE (Sleepiness) and FATIGUE (Fatigue) had resolved. At the time of the report, TENDERNESS (It is very tender), SWELLING (Swelling and puffing), PAIN (It is very sore when in motion) and ARTHRALGIA (Awaken with arthralgia right elbow) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MODERNATX, INC.-MOD-2021-020521 (E2B Linked Report).; Sender's Comments:  MODERNATX, INC.-MOD-2021-020521:Same patient, 1st dose
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Pain in extremity
Clinical narrative: Sore arm; Body aches/ Muscle aches/ Pain; Headache; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Mar-2021 and was forwarded to Moderna on 02-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches/ Muscle aches/ Pain) and HEADACHE (Headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 01-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches/ Muscle aches/ Pain) and HEADACHE (Headache). At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (Body aches/ Muscle aches/ Pain) and HEADACHE (Headache) outcome was unknown.            Patient received 2nd Moderna vaccine 01Mar2021 on left arm. She had body aches, pain, muscle aches, a sore arm, and a headache. She wanted to know if she could take an aspirin.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Fatigue
Clinical narrative: Next day woke up with shiver; Couldn't get out of bed; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Next day woke up with shiver) and FATIGUE (Couldn't get out of bed) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Thyroid disorder NOS, Prostate adenoma and Kidney disorder.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, the patient experienced CHILLS (Next day woke up with shiver) and FATIGUE (Couldn't get out of bed). At the time of the report, CHILLS (Next day woke up with shiver) and FATIGUE (Couldn't get out of bed) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive Positive.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Lethargy, Malaise, Pain
Clinical narrative: sore arm; lethargic; weak; tired; achy; not feel well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired) and PAIN (achy) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired), PAIN (achy) and MALAISE (not feel well). At the time of the report, PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired), PAIN (achy) and MALAISE (not feel well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; lethargic; weak; tired; achy; not feel well; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired) and PAIN (achy) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired), PAIN (achy) and MALAISE (not feel well). At the time of the report, PAIN IN EXTREMITY (sore arm), LETHARGY (lethargic), ASTHENIA (weak), FATIGUE (tired), PAIN (achy) and MALAISE (not feel well) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment and concomitant medications were not provided by reporter.